New-generation flu vaccine now in Phase 3 trial is looking for participants for Upstate-led medical research trial
GREENVILLE, S.C. —This week, a new clinical trial is starting in the Upstate for a new-generation flu vaccine that's being studied by GSK. They are starting their Phase III efficacy trial in partnership with Greenville-based Tribe Clinical Research.
Dr. Scott Dobson is the Medical Director at Tribe and has been a practicing pediatrician for more than two decades. He says the new vaccine is "specific for adults 65 and up and will be compared to an existing flu vaccine that's already available. So it's not a placebo trial, which is great for patients."
Many people ages 65 and up in Greenville and Spartanburg may have received postcards in the mail inviting them to participate in the trial.
Health Literacy Month: Understanding Clinical Research Starts With Asking Questions
Health information can feel overwhelming. Medical terms, test results, treatment options, medications, and online advice can make it difficult to know where to begin. Health Literacy Month is a reminder that everyone deserves clear, understandable information to help them make informed decisions about their care.
National Immunization Awareness Month: Why Staying Up to Date on Vaccines
August is National Immunization Awareness Month, a time to recognize the important role vaccines play in protecting individuals, families, and communities from preventable illnesses.
Vaccines are one of the most effective tools available to help reduce the spread and severity of infectious diseases.
Upstate clinic leads research on promising Alzheimer’s drug nearing approval
GREENVILLE, S.C. — A South Carolina research clinic is taking a primary role in the research of a drug that could attack Alzheimer’s disease.
Tribe Clinical Research in Greenville said they are in the midst of researching a drug that targets an abnormal protein that scientists link to the disease.
“I like to think of it as a clogged sink, so to speak. The treatments that are already FDA-approved today help with allowing some of the water to drain that really help with the symptoms of Alzheimer's. The drugs that we're studying today actually poke at the clog and help remove that clog bit by bit,” Jennifer Lehman said as an analogy for the drug.